Prescription-Strength Zantac Recalled By GlaxoSmithKline Over NDMA Fears
A Zantac recall announced by GlaxoSmithKline due to NDMA contamination affects all prescription-strength brand-name versions of the medication.…
«
»
A Zantac recall announced by GlaxoSmithKline due to NDMA contamination affects all prescription-strength brand-name versions of the medication.…
A new study finds Shingrix to be effective in helping prevent stem cell transplant patients from developing shingles, but frequently results in injection site reactions.…
Following a recent Supreme Court ruling, a federal judge is revisiting whether Zofran birth defect lawsuits should proceed as planned.…
An Appeals Court ruling that a Paxil suicide lawsuit was preempted by federal law was allowed to stand after the Supreme Court refused to hear the case.…
GlaxoSmithKline says it needs to expand Shingrix production amid rapidly growing demand.…
Zofran lawsuits are continuing forward after a federal judge rejected calls by GlaxoSmithKline for a summary judgment in the manufacturer’s favor.…
A new CDC report indicates a number of serious events have been linked to the use of Shingrix, but indicates the vaccine is safe overall.…
A new study shows a link between Zofran use during pregnancy and an increased risk of oral cleft defects.…
Doctors rapidly moving away from the Zostavax vaccine may be in part to blame for a shortage of Shingrix, GlaxoSmithKline’s competing vaccination, which has been overwhelmed by demand in recent months.…
A new study indicates Shingrix is more effective than Zostavax at preventing shingles, but may carry an increased risk of injection site complications.…